Investing.com – Incyte (NASDAQ: ) reported second quarter EPS of $-1.82, $2.69 worse than the analyst estimate of $0.87. Revenue for the quarter came in at $1.04B versus the consensus estimate of $1.02B.
Guidance
Incyte sees FY 2024 revenue of $2.71B-$2.75B
Incyte’s stock price closed at $68.59. It is up 29.20% in the last 3 months and up 7.64% in the last 12 months.
Incyte saw 1 positive EPS revisions and 7 negative EPS revisions in the last 90 days. See Incyte’s stock price’s past reactions to earnings here.
According to InvestingPro, Incyte’s Financial Health score is “great performance“.
Check out Incyte’s , and Incyte’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar